Merck Aktie

74,30 EUR -4,00 EUR -5,11 %

04.04.2025

STU

81,60 USD +0,10 USD +0,12 %

nachbörslich05.04.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.187,75 Mrd. EUR

KGV14,77Div. Rendite3,14%

WKNA0YD8Q

ISINUS58933Y1055

SymbolMRK

Merck Aktien News

Sortieren:Datum Meistgelesen

03.04.25ZacksMerck (MRK) Stock Moves -0.24%: What You Should Know

02.04.25BenzingaHow Do Investors Really Feel About Merck & Co?

02.04.25ZacksWall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?

WerbungMerck-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

02.04.25ZacksThe Zacks Analyst Blog Highlights Amazon.com, Oracle and Merck

01.04.25ZacksTop Analyst Reports for Amazon, Oracle & Merck

01.04.25PR NewswireClass Action Filed Against Merck & Co., Inc. (MRK) Seeking Recovery for Investors - Contact Levi & Korsinsky

31.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

28.03.25ZacksWhy the Market Dipped But Merck (MRK) Gained Today

28.03.25PR NewswireMRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit

27.03.25ZacksMerck Gets EC Nod for 21-Valent Pneumococcal Jab Capvaxive

27.03.25MotleyFoolIs Merck Stock a Bargain Buy?

26.03.25ZacksMerck (MRK) Gains As Market Dips: What You Should Know

26.03.25ZacksMerck Inks $2B Licensing Deal With Chinese Biotech for Oral Heart Drug

26.03.25BenzingaGamestop, FST Corp, Merck, UPS, And Tesla: Why These 5 Stocks Are On Investors' Radars Today

25.03.25BenzingaMerck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment

25.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

25.03.25PR NewswireMRK Investors Have Final Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit with the Schall Law Firm

21.03.25PR NewswireLevi & Korsinsky Notifies Merck & Co., Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MRK

19.03.25ZacksMerck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade

19.03.25ZacksMerck Loses Almost $52B in 6 Months: How to Play MRK Stock

19.03.25PR NewswireHealth Canada Approves KEYTRUDA® for the Treatment of Adult Patients with Primary Advanced or Recurrent Endometrial Carcinoma, in Combination with Carboplatin and Paclitaxel and then Continued as ...

18.03.25BenzingaMerck & Co's Options: A Look at What the Big Money is Thinking

17.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

14.03.25BenzingaA Closer Look at Merck & Co's Options Market Dynamics

13.03.25ZacksMerck (MRK) Advances While Market Declines: Some Information for Investors

13.03.25ZacksMerck (MRK) Is Considered a Good Investment by Brokers: Is That True?

13.03.25PR NewswireMerck & Co., Inc. Class Action: The Gross Law Firm Reminds Merck Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 14, 2025 - MRK

12.03.25ZacksMerck (MRK) Stock Drops Despite Market Gains: Important Facts to Note

12.03.25BenzingaHow Do Investors Really Feel About Merck & Co?

12.03.25BenzingaMerck Plans Regulatory Submission For Two-Drug Regime For HIV Infection By Mid-2025

11.03.25BenzingaMerck Injects $1 Billion To Expand Vaccine Production In US

11.03.25ZacksZacks Investment Ideas feature highlights: Molson Coors, Merck & Co. and Deutsche Telekom

10.03.25BenzingaMerck & Co Unusual Options Activity For March 10

07.03.25PR NewswireMerck & Co., Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - MRK

06.03.25ZacksMerck (MRK) Ascends While Market Falls: Some Facts to Note

06.03.25ZacksMerck (MRK) Up 3.9% Since Last Earnings Report: Can It Continue?

04.03.25BenzingaSpotlight on Merck & Co: Analyzing the Surge in Options Activity

03.03.25PR NewswireMRK Purchasers Have Opportunity to Lead Merck & Co., Inc. Securities Fraud Lawsuit

03.03.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Merck & Co., Inc. of Class Action Lawsuit and Upcoming Deadlines - MRK

Merck News

Merck News: auf dieser Seite finden Sie alle Merck News und Nachrichten zur Merck Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Merck News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Merck News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.